These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26422474)

  • 1. High Treatment Retention Rate in HIV-Infected Patients Receiving Antiretroviral Therapy at Two Large HIV Clinics in Hanoi, Vietnam.
    Matsumoto S; Tanuma J; Mizushima D; Nguyen NC; Pham TT; Do CD; Nguyen TQ; Nguyen DT; Nguyen HD; Nguyen LT; Nguyen KV; Oka S
    PLoS One; 2015; 10(9):e0139594. PubMed ID: 26422474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss to follow-up among youth accessing outpatient HIV care and treatment services in Kisumu, Kenya.
    Ojwang' VO; Penner J; Blat C; Agot K; Bukusi EA; Cohen CR
    AIDS Care; 2016; 28(4):500-7. PubMed ID: 26565428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective analysis of antiretroviral therapy uptake and retention of male clients receiving methadone maintenance therapy in two provinces in Vietnam: potential synergy of the two therapies.
    Pham LT; Kitamura A; Do HM; Lai KA; Le NT; Nguyen VT; Kato M
    Harm Reduct J; 2017 Feb; 14(1):12. PubMed ID: 28212645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are they really lost? "true" status and reasons for treatment discontinuation among HIV infected patients on antiretroviral therapy considered lost to follow up in Urban Malawi.
    Tweya H; Feldacker C; Estill J; Jahn A; Ng'ambi W; Ben-Smith A; Keiser O; Bokosi M; Egger M; Speight C; Gumulira J; Phiri S
    PLoS One; 2013; 8(9):e75761. PubMed ID: 24086627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Status of HIV-infected patients classified as lost to follow up from a large antiretroviral program in southwest Nigeria.
    Balogun M; Meloni ST; Igwilo UU; Roberts A; Okafor I; Sekoni A; Ogunsola F; Kanki PJ; Akanmu S
    PLoS One; 2019; 14(7):e0219903. PubMed ID: 31344057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retention in care among HIV-positive patients initiating second-line antiretroviral therapy: a retrospective study from an Ethiopian public hospital clinic.
    Wilhelmson S; Reepalu A; Balcha TT; Jarso G; Björkman P
    Glob Health Action; 2016; 9():29943. PubMed ID: 26765104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of loss to follow-up among patients on ART at a rural hospital in KwaZulu-Natal, South Africa.
    Arnesen R; Moll AP; Shenoi SV
    PLoS One; 2017; 12(5):e0177168. PubMed ID: 28542309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for loss to follow-up, transfer or death among people living with HIV on their first antiretroviral therapy regimen in Mali.
    Baldé A; Lièvre L; Maiga AI; Diallo F; Maiga IA; Costagliola D; Abgrall S
    HIV Med; 2019 Jan; 20(1):47-53. PubMed ID: 30270487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postnatal retention in HIV care: insight from the Swiss HIV Cohort Study over a 15-year observational period.
    Aebi-Popp K; Kouyos R; Bertisch B; Staehelin C; Rudin C; Hoesli I; Stoeckle M; Bernasconi E; Cavassini M; Grawe C; Lecompte TD; Rickenbach M; Thorne C; Martinez de Tejada B; Fehr J; ;
    HIV Med; 2016 Apr; 17(4):280-8. PubMed ID: 26268702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early loss to follow-up of recently diagnosed HIV-infected adults from routine pre-ART care in a rural district hospital in Kenya: a cohort study.
    Hassan AS; Fielding KL; Thuo NM; Nabwera HM; Sanders EJ; Berkley JA
    Trop Med Int Health; 2012 Jan; 17(1):82-93. PubMed ID: 22943164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in mortality and loss to follow-up in HIV care at the Nkongsamba Regional hospital, Cameroon.
    Bekolo CE; Webster J; Batenganya M; Sume GE; Kollo B
    BMC Res Notes; 2013 Dec; 6():512. PubMed ID: 24308609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Life expectancy of HIV-positive individuals on combination antiretroviral therapy in Canada.
    Patterson S; Cescon A; Samji H; Chan K; Zhang W; Raboud J; Burchell AN; Cooper C; Klein MB; Rourke SB; Loutfy MR; Machouf N; Montaner JS; Tsoukas C; Hogg RS;
    BMC Infect Dis; 2015 Jul; 15():274. PubMed ID: 26183704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors Associated with Loss to Follow-Up Among Patients Receiving HIV Treatment in Nairobi, Kenya.
    Koech E; Stafford KA; Mutysia I; Katana A; Jumbe M; Awuor P; Lavoie MC; Ngunu C; Riedel DJ; Ojoo S
    AIDS Res Hum Retroviruses; 2021 Sep; 37(9):642-646. PubMed ID: 33913735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss to follow-up in the Australian HIV Observational Database.
    McManus H; Petoumenos K; Brown K; Baker D; Russell D; Read T; Smith D; Wray L; Giles M; Hoy J; Carr A; Law MG;
    Antivir Ther; 2015; 20(7):731-41. PubMed ID: 25377928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Illicit drug use is a significant risk factor for loss to follow up in patients with HIV-1 infection at a large urban HIV clinic in Tokyo.
    Nishijima T; Gatanaga H; Komatsu H; Takano M; Ogane M; Ikeda K; Oka S
    PLoS One; 2013; 8(8):e72310. PubMed ID: 23951307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of a nurse-managed service for stable HIV-positive patients in a large South African public sector antiretroviral therapy programme.
    Grimsrud A; Kaplan R; Bekker LG; Myer L
    Trop Med Int Health; 2014 Sep; 19(9):1029-39. PubMed ID: 25041716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aging and loss to follow-up among youth living with human immunodeficiency virus in the HIV Research Network.
    Agwu AL; Lee L; Fleishman JA; Voss C; Yehia BR; Althoff KN; Rutstein R; Mathews WC; Nijhawan A; Moore RD; Gaur AH; Gebo KA
    J Adolesc Health; 2015 Mar; 56(3):345-51. PubMed ID: 25703322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement in mortality and retention among adult HIV-infected patients in the first 12 months of antiretroviral therapy in Dodoma urban district, Tanzania.
    Tweve EN; Kayabu D; Nassari NO; Todd J
    Trop Med Int Health; 2015 Jun; 20(6):791-6. PubMed ID: 25706518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disclosure of HIV status and its impact on the loss in the follow-up of HIV-infected patients on potent anti-retroviral therapy programs in a (post-) conflict setting: A retrospective cohort study from Goma, Democratic Republic of Congo.
    Akilimali PZ; Musumari PM; Kashala-Abotnes E; Kayembe PK; Lepira FB; Mutombo PB; Tylleskar T; Ali MM
    PLoS One; 2017; 12(2):e0171407. PubMed ID: 28170410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-reported Reasons for Stopping Care or Switching Clinics in Zambia: A Multisite, Regionally Representative Estimate Using a Multistage Sampling-based Approach in Zambia.
    Sikazwe I; Eshun-Wilson I; Sikombe K; Beres LK; Somwe P; Mody A; Simbeza S; Bukankala C; Glidden DV; Mulenga LB; Padian N; Ehrenkranz P; Bolton-Moore C; Holmes CB; Geng EH
    Clin Infect Dis; 2021 Oct; 73(7):e2294-e2302. PubMed ID: 33011803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.